LINK ALTERNATIF MBL77 Options
Not all people with CLL call for therapy. In spite of all recent developments, the iwCLL however endorses watchful observation for patients with asymptomatic ailment.86 This advice is based on no less than two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Nikmati sens